Zobrazeno 1 - 4
of 4
pro vyhledávání: '"I. A. Zhevagina"'
Autor:
T. I. Petelina, N. A. Musikhina, V. D. Garanina, A. E. Shcherbinina, K. S. Avdeeva, L. L. Valeeva, A. S. Kalugin, A. A. Kapustina, S. N. Suplotov, S. V. Leonovich, I. A. Zhevagina, A. D. Sapozhnikova, E. I. Yaroslavskaya, L. I. Gapon
Publikováno v:
Ожирение и метаболизм, Vol 19, Iss 4, Pp 387-395 (2023)
BACKGROUND: According to the results of the ESSE-RF study, the frequency of obesity in the population reached 29.7%. Obesity is one of the main risk factors for the development of cardiovascular diseases. Features of the course of COVID-19 in patient
Externí odkaz:
https://doaj.org/article/b0c7f4a464d648c1958c447baf31476e
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 2, Pp 26-29 (2004)
The trial included 56 patients (mean age 51.8 ± 0. 8) with metabolic syndome (MS): arterial hypertension - AH (mean stage of AH 11.45 ± 1.1 yrs), non-insuline-dependent diabetes mellitus (mean stage 6. 7+0. 7 yrs), abdominal adiposity, and dyslipid
Externí odkaz:
https://doaj.org/article/122be908d82d4355b28491595b4b04aa
Publikováno v:
Terapevticheskii arkhiv. 77(8)
To compare hypotensive and antiischemic efficacy of enalapril combination with trimetazidine or placebo, effects on plasmic lipid spectrum and membrane-cell parameters of erythrocytes and platelets in hypertensive patients with ischemic heart disease
Autor:
T I, Petelina, L I, Gapon, Iu A, Bakhmatova, I A, Zhevagina, V A, Kalinina, V V, Todosiĭchuk, V A, Kuznetsov
Publikováno v:
Kardiologiia. 45(8)
Efficacy of combination of trimetazidine (60 mg/day) and enalapril in patients with stable effort angina and metabolic syndrome was assessed in a randomized placebo controlled study of 64 patients. Anti-ischemic activity of trimetazidine was found to